Practice
Featured experience
InSilico Medicine HK$2.62 billion IPO
We advised InSilico Medicine on its IPO and HKEX listing
Mastercard $1.8 billion acquisition of BVNK
We are advising Mastercard on the transaction
Sycamore Partners up to $23.7 billion acquisition of Walgreens Boots Alliance
We are advising Sycamore Partners on the transaction
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
PGE stock offering and forward sale agreement
The stock is listed on the NYSE
Recursion Pharmaceuticals $150 million private placement
We advised the placement agents on the private placement of common stock
Canopy Growth credit agreement amendment
We advised certain lenders under the term loan credit facility
Fifth Third Bancorp $1 billion senior notes offering
The investment-grade notes are due 2028
Fifth Third Bank $1 billion senior notes offering
The investment-grade notes are due 2025
ADT $1.2 billion cash tender offer for stock
The company’s shares are traded on the NYSE
First Transit acquisition by Transdev North America
We are advising FirstGroup on the transaction
Prime Medicine $175 million IPO
The shares are listed on the Nasdaq Global Market
RXO $355 million notes offering
The notes are being offering in connection with the intended spinoff of RXO
Denali Therapeutics $316 million follow-on offering
The shares are listed on the Nasdaq Global Select Market